Michaela Fleming

Public Health England recommends individuals at higher risks for influenza receive a newly available adjuvanted trivalent influenza vaccine this winter.

The US Preventative Services Task Force recommends early screening for syphilis in pregnant women and a literature review has reinforced the recommendations.

Investigators from the NIH have launched a phase 1 clinical trial to assess if a topical cream administered prior to H5N1 vaccination can enhance immune response.

An international literature review indicates that 78% of children with multidrug-resistant tuberculosis were successfully treated with second-line treatment.

In a new study, investigators found that providing guidance and advice in people who inject drugs increased use of antiretroviral medication use by 30%.

The CDC and FDA are investigating a multistate outbreak of Salmonella Enteritidis linked with Gravel Ridge Farms shell eggs.

A team of investigators have discovered a new way to link samples submitted for TB testing to individuals who provided them as well as where the sample was collected.

Results of the 2016 European Gonococcal Antimicrobial Surveillance Program report a steady rise in drug resistant-gonorrhea infections.

The FDA has approved Grifols’ new formulation of immune globulin (GamaSTAN) for hepatitis A virus and measles post-exposure prophylaxis.

A Legionnaires’ disease outbreak in New Hampshire has been linked to at least 1 resort in the town of Hampton.

Ebola is not the only infectious disease that health officials in the Democratic Republic of the Congo are struggling with.

New practical advice for the treatment of C difficile from SHEA advises against routine testing in NICU patients with diarrhea.

Investigators find that only 48% of surveyed health care providers had ever prescribed PrEP.

A new study has uncovered how cytomegalovirus can bypass the body’s defense mechanisms that prevent viral infections.

Investigators from Loyola Medicine have developed a 3-pronged model that could identify patients at risk for acute respiratory distress syndrome.

CDC Antibiotic Resistance Laboratory Network has launched a pilot program using printers with antibiotic susceptibility testing panels.

A new study by St. Jude Children’s Research Hospital reported that gamma delta (γδ) T cells play a key role in protecting infants from flu complications.

The CDC has announced an investigation of a multistate outbreak of Salmonella I 4,[5],12:i:- infections that have been linked with kosher chicken.

West Virginia’s Bureau for Public Health has requested the assistance from the CDC to contain the statewide hepatitis A outbreak.

A universal flu vaccine candidate elicits protective response in mice against multiple strains of the virus.

In a wounded mouse model concurrently infected with influenza A, investigators observed that the innate immune system prioritized responding to the lung infection, delaying wound healing.

The Democratic of the Congo Ministry of Health has authorized the use of 5 experimental Ebola treatments as more than 100 cases of Ebola are reported.

A new analysis by CDC investigators found that nearly 1 in 400 children aged

The FDA has added Lassa fever, chikungunya virus disease, rabies, and cryptococcal meningitis to the tropical disease Priority Review Voucher Program.

We’ve rounded up the Salmonella outbreaks that have been declared by the US Centers for Disease Prevention and Control so far this summer.

A new study reveals that the quadrivalent HPV catch-up vaccine was most effective against cancer risk in women who received the first dose between the ages of 14 and 20 years.

The NIH has begun a phase 1 trial assessing the safety of rZIKV/D4Δ30-713, a Zika virus vaccine.

Over 400 individuals have been infected with Cyclospora across 15 states in an outbreak linked to McDonald’s salads.

New research from Johns Hopkins reveals that 2 genes, CMPK2 and BCLG, are selectively activated in the presence of type 1 interferon.

Use of ibalizumab in combination with other HIV treatment could be an effective option for adults with advanced drug-resistant HIV.